EKR Therapeutics makes appointment
05 March 2010
Zoe Dann
Please Login to read the full article.
05 March 2010
Zoe Dann
zoe.dann@informa.com
EKR Therapeutics (US), a speciality pharmaceutical company focused on the commercialisation of acute-care hospital products, has appointed its executive chairman, John Bailye, as interim president and chief executive officer. He replaces Howard Weisman, who is no longer with the company.
Please Login to read the full article.
RELATED CONTENT
NEWS
- Broad swathe of measures to support UK life sciences draws widespread applause
- Biopharma-academic partnerships on the rise, but negotiations remain a rough ride
- Sykes to head $250 million Deepbridge fund that "feeds its own children"
- Panic! No, don't panic! ECJ embryonic stem cells ruling divides opinion
COMMENT
Other Informa Comment
FEATURES
- Merck BioVentures: where biosimilars make a difference
- DKSH highlights one-stop benefits as it builds Asia market expansion services
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
